Before the coronavirus disease 2019 (COVID-19) pandemic, over 4000 people were dying from tuberculosis (TB) every day [1]. As with past emergencies [2], the impact of COVID-19 on TB outcomes is a serious cause for concern [3] but is currently unknown. Health system overload, due to high numbers of COVID-19 cases, as well as interventions necessary to limit the transmission of severe acute…
B-cells are recruited to and activated in PAH lungs and contribute to vascular remodelling through production of autoantibodies targeting the lung vasculature and cytokines. B-cell…
This book is now available for pre-order. All pre-orders will be dispatched when the book is published in June 2024. Edited by Alexandra M. Nanzer, Peter…
This protocol describes the process of developing a performance-based toolkit to assess the key treatable traits of functioning in hospitalised patients with ECOPD in order…
Smoking cessation at lung cancer screening is viable and an excellent opportunity https://bit.ly/3TC0HAf
The ongoing French RAMSES cohort includes more than 2000 severe asthma patients, with differences in terms of phenotype and asthma care trajectories between secondary and…
This book is now available for pre-order. All pre-orders will be dispatched when the book is published in June 2024. Edited by Alexandra M. Nanzer, Peter…
Our growing understanding of how the epithelium and epithelial cytokines orchestrate airway remodelling in severe asthma is enabling the development of new therapies that may…
“Digital transformation is already happening. It’s not a question of if, but how.” The restrictions of the COVID-19 pandemic changed the landscape of digital healthcare…
The FIS assay generally indicates responsiveness to CFTR modulators, but it cannot discriminate between high and low responders within the F508del homozygous subjects. Higher FIS…
As part of the April issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Ritesh Agarwal…
